Highbridge Capital Management’s Edwards Lifesciences EW Stock Holding History

Highbridge Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,849	Closed	-$458K	–	1043
2018 Q1	$458K	Sell	9,849 -294,981	-97%	-$12.8M	0.01%	730
2017 Q4	$11.5M	Sell	304,830 -81,414	-21%	-$2.99M	0.2%	134
2017 Q3	$14.1M	Buy	+386,244	New	+$14.7M	0.21%	131
2017 Q2	–	Sell	-200,829	Closed	-$6.3M	–	1345
2017 Q1	$6.3M	Buy	+200,829	New	+$6.29M	0.09%	267
2016 Q3	–	Sell	-37,896	Closed	-$1.26M	–	1404
2016 Q2	$1.26M	Sell	37,896 -2,607	-6%	-$89.2K	0.02%	551
2016 Q1	$1.19M	Sell	40,503 -3,867	-9%	-$107K	0.02%	675
2015 Q4	$1.17M	Buy	+44,370	New	+$1.15M	0.02%	692
2015 Q2	–	Sell	-100,878	Closed	-$2.4M	–	1479
2015 Q1	$2.4M	Sell	100,878 -655,530	-87%	-$14.7M	0.03%	487
2014 Q4	$16.1M	Sell	756,408 -1,710,780	-69%	-$34.4M	0.21%	153
2014 Q3	$42M	Buy	2,467,188 +2,238,720	+980%	+$35.3M	0.55%	41
2014 Q2	$3.27M	Buy	+228,468	New	+$3.1M	0.04%	317
2014 Q1	–	Sell	-1,976,334	Closed	-$21.7M	–	1101
2013 Q4	$21.7M	Buy	1,976,334 +1,178,760	+148%	+$13.3M	0.26%	118
2013 Q3	$9.26M	Buy	+797,574	New	+$9.33M	0.1%	244

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Highbridge Capital Management's EW Position: Q2 2018 in Review

Highbridge Capital Management sold out of Edwards Lifesciences (EW) in Q2 2018, closing a stake of 9,849 shares — an estimated $458K sold.

Highbridge Capital Management first reported a position in EW in Q3 2013 and held it in 13 quarters. The position peaked at $42M in Q3 2014. 839 funds tracked by Wall St. Rank hold EW as of Q2 2018.

Highbridge Capital Management reported no remaining Edwards Lifesciences position as of Q2 2018 after selling out during the quarter.
Highbridge Capital Management sold 9,849 Edwards Lifesciences shares in Q2 2018, an estimated $458K.
Highbridge Capital Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 13 quarters.
Highbridge Capital Management's Edwards Lifesciences position peaked at $42M in Q3 2014.
839 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.